These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24465730)

  • 41. Structural properties of bioactive peptides with α-glucosidase inhibitory activity.
    Ibrahim MA; Bester MJ; Neitz AWH; Gaspar ARM
    Chem Biol Drug Des; 2018 Feb; 91(2):370-379. PubMed ID: 28884942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors.
    Javaid K; Saad SM; Rasheed S; Moin ST; Syed N; Fatima I; Salar U; Khan KM; Perveen S; Choudhary MI
    Bioorg Med Chem; 2015 Dec; 23(23):7417-21. PubMed ID: 26552899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Docking and QSAR analysis of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
    Asadollahi-Baboli M; Dehnavi S
    Comput Biol Chem; 2018 Oct; 76():283-292. PubMed ID: 30103106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effect of phloretin on α-glucosidase: Kinetics, interaction mechanism and molecular docking.
    Han L; Fang C; Zhu R; Peng Q; Li D; Wang M
    Int J Biol Macromol; 2017 Feb; 95():520-527. PubMed ID: 27894824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular docking of polyoxometalates as potential α-glucosidase inhibitors.
    Hu J; Wang L; Wang F; Chi G; Liu G; Sun L
    J Inorg Biochem; 2020 Feb; 203():110914. PubMed ID: 31751818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies.
    Avula SK; Khan A; Rehman NU; Anwar MU; Al-Abri Z; Wadood A; Riaz M; Csuk R; Al-Harrasi A
    Bioorg Chem; 2018 Dec; 81():98-106. PubMed ID: 30118991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
    Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
    J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A computational strategy to understand structure-activity relationship of 1,3-disubstituted imidazole [1,5-α] pyrazine derivatives described as ATP competitive inhibitors of the IGF-1 receptor related to Ewing sarcoma.
    Guaitoli V; Alvarez-Ginarte YM; Montero-Cabrera LA; Bencomo-Martínez A; Badel YP; Giorgetti A; Suku E
    J Mol Model; 2020 Aug; 26(8):222. PubMed ID: 32748063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In silico ligand binding studies of cyanogenic β-glucosidase, dhurrinase-2 from Sorghum bicolor.
    Mahajan C; Patel K; Khan BM; Rawal SS
    J Mol Model; 2015 Jul; 21(7):184. PubMed ID: 26139075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking.
    Yar M; Bajda M; Shahzadi L; Shahzad SA; Ahmed M; Ashraf M; Alam U; Khan IU; Khan AF
    Bioorg Chem; 2014 Jun; 54():96-104. PubMed ID: 24880489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of highly potent α-glucosidase inhibitory and antioxidant constituents from Zizyphus rugosa bark: enzyme kinetic and molecular docking studies with active metabolites.
    Sichaem J; Aree T; Lugsanangarm K; Tip-Pyang S
    Pharm Biol; 2017 Dec; 55(1):1436-1441. PubMed ID: 28320255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of novel flavonoid alkaloids as α-glucosidase inhibitors.
    Zhen J; Dai Y; Villani T; Giurleo D; Simon JE; Wu Q
    Bioorg Med Chem; 2017 Oct; 25(20):5355-5364. PubMed ID: 28797772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.
    Peytam F; Adib M; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Mahdavi M; Moghadamnia AA; Rastegar H; Larijani B
    Mol Divers; 2020 Feb; 24(1):69-80. PubMed ID: 30825061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives.
    Ullah H; Rahim F; Taha M; Hussain R; Wadood A; Nawaz M; Wahab Z; Kanwal ; Khan KM
    Med Chem; 2020; 16(6):724-734. PubMed ID: 31195948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational prediction integrating the inhibition kinetics of gallotannin on α-glucosidase.
    Yue LM; Lee J; Zheng L; Park YD; Ye ZM; Yang JM
    Int J Biol Macromol; 2017 Oct; 103():829-838. PubMed ID: 28539267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition mechanism of ferulic acid against α-amylase and α-glucosidase.
    Zheng Y; Tian J; Yang W; Chen S; Liu D; Fang H; Zhang H; Ye X
    Food Chem; 2020 Jul; 317():126346. PubMed ID: 32070843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
    Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.